Lifecore Biomedical Inc
Uždarymo kaina
SektoriusVartotojų apsauga
4.08 -0.24
Apžvalga
Akcijų kainos pasikeitimas
24 val.
Min
4.04
Max
4.16
Pajamos | 9.8M -6.2M |
|---|---|
Pardavimai | 11M 34M |
Pelno marža | -18.017 |
Darbuotojai | 382 |
Kitas uždarbis | 2026-12-10 |
|---|
Rinkos kapitalizacija | -20M 140M |
|---|---|
Ankstesnė atidarymo kaina | 4.32 |
Ankstesnė uždarymo kaina | 4.08 |
Naujienos nuotaikos
By Acuity
50%
50%
56 / 130 reitingas Consumer defensive
Lifecore Biomedical Inc Grafikas
Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.
Susijusios naujienos
Akcijų palyginimas
Kainos pokytis
Lifecore Biomedical Inc Prognozė
Rinkos nuotaikos
By Acuity
56 / 130 reitingas Vartotojų apsauga
Naujienos nuotaikos
Neutral
Svyravimai
Žemiau vidurkio
Naujienų apimtis (RCV)
Aukščiau vidurkio
Finansinės naujienos
Pardavimo ir administravimo išlaidos
Veiklos sąnaudos
Ikimokestinis pelnas
Pardavimai
Pardavimo savikaina
Bendrasis pelnas iš pardavimo
Skolų palūkanų išlaidos
EBITDA
Veiklos pelnas
$
Apie bendrovę Lifecore Biomedical Inc
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.